All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe
Advertisement

Champix recommended by UK body

June 15, 2007
Article

The National Institute for Health and Clinical Excellence (NICE) in the UK has recommended Pfizer?s Champix (varenicline) for use on the NHS for adult smokers who have expressed a desire to quit.

The National Institute for Health and Clinical Excellence (NICE) in the UK has recommended Pfizer's Champix (varenicline) for use on the NHS for adult smokers who have expressed a desire to quit. This gives UK smokers access to another important treatment option to help them quit their addiction.

NICE concluded that varenicline was "superior to NRT [nicotine replacement therapy] and bupropion in achieving continuous abstinence." In light of this, the agency declared that its use in smoking cessation was "likely to be a cost-effective use of NHS resources".

"This guidance means that smokers who are serious about stopping have another choice from a good range of clinically proven treatments," said Robert West, professor of Health Psychology at University College London. "Smokers who combine treatments with the right support — for instance from smoking cessation services — could significantly increase their odds of successfully quitting for life."

Chantix (varenicline) received FDA approval as an aid to smoking cessation in May last year. In the EU, Champix received marketing authorization in September 2006 for the same purpose. The drug was developed by Pfizer as such an aid through its novel mechanism of action targeting the specific receptor to which nicotine binds. It is believed to work by reducing the severity of the smoker's urge to smoke. It blocks the pleasure receptors in the brain associated with cigarette smoking and nicotine, and reduces the level of withdrawal symptoms that often cause a return to the addiction.

Smoking, the leading cause of preventable death worldwide, is responsible for five million deaths each year. By 2010,WHO estimates the annual global cost of tobacco-related illness to be approximately $500 billion.

www.pfizer.com

Recent Videos
Related Content

Pharmaceutical research and development in laboratory, with focus on medicine preparation, powder substances, and glass vials for drug formulation and testing | Image Credit: © felix_brönnimann - stock.adobe.com

Dosage Form Compounding in the Workplace Environment

Paul L. Pluta;Alan M. Mancini;Nishant B. Thakar;Varanya Chaiyaperm
July 8th 2025
Article

An ordered pharmaceutical compounding process for use in 503A pharmacies, 503B outsourcing facilities, pharmaceutical industry, and other applications.


Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.


Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Sandoz Recalls Cefazolin Due to Mispackaging, Opens Biosimilar Facility in Slovenia

Susan Haigney
July 2nd 2025
Article

The company is voluntarily recalling one lot of cefazolin for injection, USP, 1 gram per vial due to customer complaints of the wrong product being included in a carton.


Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
May 28th 2024
Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Six Biosimilars Part of EMA’s Authorization Recommendations in June

Susan Haigney
June 23rd 2025
Article

A total of 13 drugs were granted recommendation for market authorization at EMA’s CHMP June 2025 meeting.


Pharmacist weighing chemical | Image Credit: © Kzenon - stock.adobe.com

Pharmaceutical Compounding Calculations, Part Two–Bulk Drugs

Paul L. Pluta;Nishant B. Thakar;Varanya Chaiyaperm
June 23rd 2025
Article

Bulk drug calculations for different types of active moieties and drugs require different calculations and labeling.

Related Content

Pharmaceutical research and development in laboratory, with focus on medicine preparation, powder substances, and glass vials for drug formulation and testing | Image Credit: © felix_brönnimann - stock.adobe.com

Dosage Form Compounding in the Workplace Environment

Paul L. Pluta;Alan M. Mancini;Nishant B. Thakar;Varanya Chaiyaperm
July 8th 2025
Article

An ordered pharmaceutical compounding process for use in 503A pharmacies, 503B outsourcing facilities, pharmaceutical industry, and other applications.


Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.


Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Sandoz Recalls Cefazolin Due to Mispackaging, Opens Biosimilar Facility in Slovenia

Susan Haigney
July 2nd 2025
Article

The company is voluntarily recalling one lot of cefazolin for injection, USP, 1 gram per vial due to customer complaints of the wrong product being included in a carton.


Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
May 28th 2024
Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Six Biosimilars Part of EMA’s Authorization Recommendations in June

Susan Haigney
June 23rd 2025
Article

A total of 13 drugs were granted recommendation for market authorization at EMA’s CHMP June 2025 meeting.


Pharmacist weighing chemical | Image Credit: © Kzenon - stock.adobe.com

Pharmaceutical Compounding Calculations, Part Two–Bulk Drugs

Paul L. Pluta;Nishant B. Thakar;Varanya Chaiyaperm
June 23rd 2025
Article

Bulk drug calculations for different types of active moieties and drugs require different calculations and labeling.

About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.